Innovation uptake has played a significant role in strengthening response to covid-19 pandemic globally. Some of these innovations are newly developed and others a modification of existing technologies. The goal is to share information on the technological innovations that have already made a difference in other parts of the World for Adaptation and scaling in the African region.
MP Diagnostics HIV Blot 2.2

MP Diagnostics HIV Blot 2.2

MP Biomedicals Asia Pacific, Singapore
Singapore
NEW LAV BLOT I

NEW LAV BLOT I

Bio-Rad Laboratories Steenvoorde
France
NEW LAV BLOT II

NEW LAV BLOT II

Bio-Rad Laboratories Steenvoorde
France
Abbott PRISM HIV Ag/Ab Combo Assa

Abbott PRISM HIV Ag/Ab Combo Assa

Abbott Diagnostics, Wiesbaden, Germany
Germany
AiD anti-HIV 1+2 ELISA

AiD anti-HIV 1+2 ELISA

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Enzygnost HIV Integral 4
and Supplementary reagents kit for
Enzygnost®/TMB

Enzygnost HIV Integral 4 and Supplementary reagents kit for Enzygnost®/TMB

Siemens Healthcare Diagnostics Products GmbH Marburg, Germany
Germany
GenScreen™ HIV 1/2 Version 2

GenScreen™ HIV 1/2 Version 2

Bio-Rad Laboratories, Marnes La Coquette, France and Bio-Rad Laboratories, Steenvoorde, France
France
GenScreen™ ULTRA HIV Ag-Ab

GenScreen™ ULTRA HIV Ag-Ab

Bio-Rad Laboratories, Steenvoorde, France
France
HIV 1&2 Ab, cut-off

HIV 1&2 Ab, cut-off

Dialab GmbH, Austria
Austria
LIAISON XL

LIAISON XL

DiaSorin S.p.A., Saluggia (Vercelli), Italy
Italy
INNOTEST HIV Ag mAb

INNOTEST HIV Ag mAb

Fujirebio Europe N.V., Ghent, Belgium
Belgium
VITROS Immunodiagnostic Products
HIV Combo Reagent Pack

VITROS Immunodiagnostic Products HIV Combo Reagent Pack

Ortho-Clinical Diagnostics, Bridgend, United Kingdom
United Kingdom